SC0062 low dose ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
66IgA腎症1

66. IgA腎症


臨床試験数 : 275 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05687890
(ClinicalTrials.gov)
April 20239/1/2023A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney DiseaseA Randomized, Double Blind, Placebo Parallel Controlled, 2 Cohorts, Multicenter Phase II Study to Investigate the Safety and Efficacy of SC0062 Capsule in Patients With Chronic Kidney Disease With AlbuminuriaDiabetic Kidney Disease;IgA NephropathyDrug: Placebo of SC0062;Drug: SC0062 low dose;Drug: SC0062 medium dose;Drug: SC0062 high doseBiocity Biopharmaceutics Co., Ltd.NULLNot yet recruiting18 Years70 YearsAll240Phase 2NULL